Predictive model for L‐type channel inhibition: multichannel block in QT prolongation risk assessment
- 3 July 2012
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 32 (10) , 858-866
Abstract
Evaluation of the proarrhythmic potential of an investigated compound is now an integral element of the safety profile required for the approval of new drugs. The human ether‐à‐go‐go‐related gene (hERG) channel blocking potency is regarded as a surrogate marker of the proarrhythmic risk at the early stages of the research and development process. However, there is no straight correlation between QT prolongation and TdP occurrence probability, and hERG inhibition potential can be an inadequate predictor of QT prolongation. The L‐type calcium channel plays a pivotal role in cardiomyocytes' physiology. Thus the main aim of this study was to develop a predictive model for drug‐triggered CaL channel inhibition and also the assessment of drug–multichannel interaction effects on the heart rate‐corrected QT interval. The data set, consisting of 123 records describing in vitro experimental settings, measured IC50 values and calculated physico‐chemical properties for 72 various chemicals, was collected. The models were tested in a modified 10‐fold cross‐validation procedure. The generalization ability of the best model was as follows: root mean squared error (RMSE) = 1.10, normalized root mean squared error (NRMSE) = 16.09%. Out of the 10 most important variables, 5 described conditions of the in vitro experiments thus their description and experiment's conditions standardization might be the key to the models better performance. The simulations performed with the ToxComp system showed that the hERG block alone causes concentration‐dependent QT prolongation, whereas when multichannel block is regarded, the effect could be reversed. For that reason, the multichannel interaction of tested compounds should be taken into consideration, in order to make the proarrhythmic risk assessment more reliable. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Inter-individual Variability in the Pre-clinical Drug Cardiotoxic Safety Assessment—Analysis of the Age–Cardiomyocytes Electric Capacitance DependenceJournal of Cardiovascular Translational Research, 2012
- Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic riskCardiovascular Research, 2011
- Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac deathHeart Rhythm, 2010
- A model for human ventricular tissueAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Cardiac Ion Channel Effects of TolterodineThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugsEuropean Heart Journal Supplements, 2001
- Native and cloned ion channels from human heart: laboratory models for evaluating the cardiac safety of new drugsEuropean Heart Journal Supplements, 2001
- Selective phenylalkylamine block of IKr over other K+ currents in guinea‐pig ventricular myocytesBritish Journal of Pharmacology, 2000
- Perturbation method for deleting redundant inputs of perceptron networksNeurocomputing, 1997
- Comparison of Ca2+ channel inhibitory effects of cibenzoline with verapamil on guinea-pig heartGeneral Pharmacology: The Vascular System, 1991